Anna Lyczak
Overview
Explore the profile of Anna Lyczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juszczyk J, Baka-Cwierz B, Beniowski M, Berak H, Bolewska B, Boron-Kaczmarska A, et al.
Przegl Epidemiol
. 2006 Jan;
59(3):651-60.
PMID: 16433307
Unlabelled: We evaluated the efficacy and safety of peginterferon alfa-2a [40KD] (Peg-IFNalpha-2a) plus ribavirin in patients with chronic hepatitis C in an open-label programme in a routine clinical setting in...
2.
Tomasiewicz K, Modrzewska R, Lyczak A, Polz-Dacewicz M, Rajtar B
Ann Univ Mariae Curie Sklodowska Med
. 2005 Sep;
59(2):539-42.
PMID: 16146144
TT virus (TTV) was first isolated in 1997 from the patient with acute posttransfusion hepatitis. This fact led to the conclusion the virus was hepatotropic and could be considered as...
3.
Tomasiewicz K, Modrzewska R, Lyczak A, Krawczuk G
World J Gastroenterol
. 2005 May;
11(18):2847-9.
PMID: 15884138
TT virus (TTV) was first isolated in 1997 from the patient with acute post-transfusion hepatitis. This fact led to the conclusion that the virus was hepatotropic and could be one...
4.
Juszczyk J, Bialkowska J, Bolewska B, Boron-Kaczmarska A, Gladysz A, Halota W, et al.
Pol Merkur Lekarski
. 2004 Nov;
16(94):353-7.
PMID: 15517932
150 adult patients were assigned pegylated interferon alpha-2b (once weekly 1.5 microg/kg) plus ribavirin (800-1200 mg depending on bodyweight). The treatment lasted 52 weeks and was completed by 139 persons...